{"id":"F2007B01033","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2002)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62493,"registerId":"commonwealth-F2007B01033-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2002)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 1 of 2002\n\nI, JAMES McLAREN FOX, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 February 2002.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\n“Aminogran Mineral Mixture”\n\nOestradiol Valerate and Oestradiol Valerate with Medroxyprogesterone Acetate\n\nRed-back Spider Antivenom\n\nStreptokinase\n\nDated this 8th day of January 2002.\n\nJAMES McLAREN FOX\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2477},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration performs a narrow, specific administrative function exactly as authorised by the parent Act—removing four named pharmaceuticals from subsidy after obtaining committee advice. There is no expansion beyond the statutory authority to delist specific items."},"complexity_factors":["Only four specific drug listings in the Schedule with no subordinate provisions","Single operative clause performing one clear action (cessation of PBS coverage)","No defined terms, interpretation sections, or conditional logic","Minimal cross-referencing limited to the empowering provision (s 85 of the National Health Act)"],"plain_english_summary":"This declaration removes four medicines—Aminogran Mineral Mixture, oestradiol valerate (and combinations with medroxyprogesterone acetate), red‑back spider antivenom and streptokinase—from Australia’s PBS effective 1 February 2002. Affected patients, prescribers and pharmacists lose subsidy access; patients will pay full commercial prices unless supplied through hospitals or special programs, reducing affordability and access, notably for antivenom and clot‑busting treatment."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2002/documents"}}